Furthermore, a strong correlation was observed between G-CSF immunoreactivity in patients’ tumors and peripheral neutrophil count, and between G-CSF immunoreactivity and decreased survival, suggesting that the granulopoiesis induced by tumor-derived G-CSF might be the root of tumor-related neutrophilia that finally correlates with poor outcomes. This evidence concerns the gene CSF3 and neoplasm.